Randomized trial demonstrates effective synthesis of pyrano compounds using a novel organocatalyst, highlighting sustainability.
]pyrazole and pyranochromene derivatives utilizing 1,1-diaminobenzalazine as an organocatalyst has been reported. The uniqueness of this protocol lies in its broad functional-group tolerance, showcasing the use of activated ketones bearing a trifluoromethyl group and prefunctionalized sulfonamide-based pyrazolones as key substrates. The catalyst could be recycled up to 5 cycles with only a minimal loss of yield. Mechanistic insights provided by DFT studies confirmed the importance and bifunctional character of the organocatalyst. Green chemistry metrics benchmark this process as a step forward in the development of environmentally friendly and scalable methodologies, contributing to the broader goal of sustainable pharmaceutical synthesis.
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: